Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
35,103,052
-
Share change
-
-106,238
-
Total reported value
-
$212,724,662
-
Put/Call ratio
-
133%
-
Price per share
-
$6.06
-
Number of holders
-
32
-
Value change
-
+$269,717
-
Number of buys
-
13
-
Number of sells
-
10
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q3 2024
As of 30 Sep 2024,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,103,052 shares.
The largest 10 holders included
BVF INC/IL, Bellevue Group AG, Soleus Capital Management, L.P., MORGAN STANLEY, RTW INVESTMENTS, LP, PFM Health Sciences, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Rhenman & Partners Asset Management AB, Rock Springs Capital Management LP, and Parkman Healthcare Partners LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.